1 year return (CAGR)
68.68%
Theravance Biopharma Inc Exchange (NASDAQ, USD)
TBPH
17.05
+0.08 (+0.47%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
15.84%
5 year return (CAGR)
-2.92%
10 year return (CAGR)
-2.15%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
876.78M
Price/Sales
8.16
Ent value
897.83M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
8.28
PEG
-
Forward P/E
12.56
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 16.94 |
| Daily high | 17.05 |
| Daily low | 16.62 |
| Daily Volume | 343K |
| All-time high | 42.56 |
| 1y analyst estimate | 17.67 |
| Beta | 0.25 |
| EPS (TTM) | 1.04 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 2 Mar 2026 |
Downside potential
Loading...
Downside potential data
| TBPH | S&P500 | |
| Current price drop from All-time high | -59.94% | -0.56% |
| Highest price drop | -84.09% | -56.47% |
| Date of highest drop | 15 Sep 2021 | 9 Mar 2009 |
| Avg drop from high | -54.46% | -10.68% |
| Avg time to new high | 107 days | 12 days |
| Max time to new high | 2231 days | 1805 days |
News
No items found